Product Images Propafenone Hydrochloride

This is a description of a clinical trial evaluating Propafenone ER at various doses over a period of 300 days. The results are presented in a table showing the amount of Propafenone ER and Placebo given on different days and the number of patients who experienced an event. The trial was discontinued on day 273 and one patient on 325 mg experienced an event on day 291 causing a 50% decline in Kaplan-Meier curves.*

This is the complete prescribing information for Propafenone Hydrochloride extended-release capsules. The medication should be stored at room temperature in a tightly closed container. The package is designed to be child-resistant, and it is important to keep all drugs out of the reach of children. The medication is manufactured by Cadla Healthcare Ltd in India and distributed by A Zydus Pharmaceuticals in the USA. No further relevant information is available due to errors.*

Propafenone Hydrochloride is a drug that comes in extended-release capsules containing 325 mg of propafenone hydrochloride. It is typically used as a prescription medication for controlling irregular heartbeats. The capsules come in a tight container, and the drugs should be kept out of the reach of children. Usual dosage instructions should be obtained from the package insert, and the capsules should be stored at 20° to 25°C. The manufacturer is Cadila Healthcare Ltd in India and is distributed by Zydus Pharmaceuticals (USA) Inc in Pennington, NJ.*

This is a description of a drug called Propafenone Hydrochloride Extended-release Capsules, which contains 425 mg of propafenone hydrochloride per capsule. The medication comes in a bottle with 60 capsules, manufactured by Cadia Healthcare Ltd in India and distributed by Zydus Pharmaceuticals (USA) Inc. The capsules should be stored at 20°C to 25°C and in a tightly sealed bottle. The usual dosage for this drug is not provided and should be reviewed in the package insert which provides the complete prescribing information. The package is child-resistant, and users are advised to keep it and all drugs out of the reach of children.*